How has it helped my organization?
The solution tells us where we need to perform actions. It makes us more efficient and measures the efficacy of the controls we've implemented. If we use a threat actor like APT28, the tool will tell us quite effectively how robust our email, web gateway, and endpoint controls are. It is an end-to-end solution for very sophisticated malware.
What is most valuable?
Endpoint testing is the most valuable feature. The product has a very good impact on our team’s productivity. We don't need to be an expert in the product to use it. The reporting capabilities are very good. I rate them ten out of ten. It's one of the most useful features because it gives you a metric for your efficacy. We use them as a baseline to manage our outcomes. The product has improved our security posture. It tells us where we need to invest. It tells us where we need to improve. The tool has been invaluable to me for what I use it for.
What needs improvement?
The product must provide consultancy for initial setup. The solution needs better marketing. It will help people to understand the product better.
For how long have I used the solution?
I have been using the solution for two years.
What do I think about the stability of the solution?
I rate the tool’s stability a ten out of ten. Since it's a SaaS service, there's nothing for me to do. We have agents on our Cymulate device, but most of the solution is with Cymulate. It is not with the customer. It is fairly easy to integrate the product with third-party solutions. We've integrated it with Microsoft Defender.
What do I think about the scalability of the solution?
The tool is scalable. We have it in all of our businesses. Our enterprise has 2000 users, but we also have the solution in small offices with 30 users. We scale the product up or down depending on our use case.
Which solution did I use previously and why did I switch?
Before Cymulate, the market hadn't evolved enough. I transitioned to it from using vulnerability management tools like Rapid7. Vulnerability management tools would tell me where I'm vulnerable. I have migrated to breach and attack simulation tools in the last two years. I bought Cymulate because we had a successful proof of concept. The company and the pricing scaled quite nicely with what we wanted.
How was the initial setup?
Cymulate is a SaaS solution. The initial setup was not difficult. We must be mindful that we're going to have some teething trouble. We found it reasonable because we ran a proof of concept first. When we put it in the enterprise, we knew the potential pitfalls.
What was our ROI?
We have seen a 100% return on investment. We're not a large information security team. The solution tells us quite explicitly where we need to focus. Other vulnerability management tools might tell us where the vulnerabilities are, but they might not tell us where to focus.
What's my experience with pricing, setup cost, and licensing?
The product is affordable. There are no additional costs associated with it.
Which other solutions did I evaluate?
We evaluated other options. The market leaders are all the same. The differentiator is price.
What other advice do I have?
I've never had to deal with technical support. We have a dedicated customer success manager. I have a weekly meeting to talk about new updates and problems. People who want to use the solution must do a proof of concept and understand their use case before buying it. It is not a vulnerability management tool.
I don't use everything the product has to offer. For my particular scenario, it works fine, and the features within the tool set are also fine. I'm in Australia. The tool is relatively new to the market in Australia. We were one of the first customers, so we have a very good relationship. I will recommend the product to anybody. Overall, I rate the solution a ten out of ten.